Press release
Bullous Keratopathy Market to Grow at a CAGR of 5.4%
Pune, India - Exactitude Consultancy: The global Bullous Keratopathy Market is projected to grow at a CAGR of 5.4% during the forecast period. Rising cases of corneal endothelial diseases, complications from cataract surgery, and improved access to corneal transplantation are major contributors to market growth. Advancements in endothelial keratoplasty and emerging regenerative therapies are reshaping the treatment landscape.Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72223
Introduction
Bullous keratopathy results from damage or dysfunction of the corneal endothelium, causing corneal edema, pain, and significant visual impairment. It is a leading cause of corneal blindness globally and a major indication for corneal transplantation. The increasing number of cataract surgeries worldwide, especially in aging populations, has contributed to a rise in postoperative endothelial failure.
With evolving surgical techniques-such as DMEK (Descemet Membrane Endothelial Keratoplasty) and DSAEK (Descemet Stripping Automated Endothelial Keratoplasty)-patients are experiencing shorter recovery times, improved outcomes, and reduced postoperative complications. Emerging cell-based therapies are also showing promising potential to reduce dependence on donor tissue.
Key Takeaways
• The Bullous Keratopathy Market is projected to grow at a CAGR of 5.4% during the forecast period.
• Endothelial keratoplasty (DMEK/DSAEK) remains the gold standard treatment for advanced cases.
• Increased global cataract surgery volumes significantly contribute to rising disease incidence.
• Emerging corneal endothelial cell injections, tissue engineering, and regenerative medicine offer new treatment pathways.
• Key players include Alcon, CorneaGen, Johnson & Johnson Vision, Bausch + Lomb, Zeiss, Emmecell, and Aerie Pharmaceuticals.
Market Drivers
• Growing prevalence of pseudophakic bullous keratopathy (PBK): Linked to rising global cataract surgeries.
• Improved availability of donor corneal tissue: Growth in eye banking infrastructure enhances surgical outcomes.
• Technological advancements in keratoplasty: DMEK and DSAEK enabling faster rehabilitation and better vision quality.
• Rise in Fuchs endothelial dystrophy cases: A major contributor to endothelial failure.
• Expansion of regenerative medicine: Endothelial cell therapy reducing reliance on donor corneas.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72223/bullous-keratopathy-market
Market Segmentation
By Treatment Type
• Endothelial Keratoplasty (DMEK, DSAEK)
• Penetrating Keratoplasty (PKP)
• Corneal Endothelial Cell Transplantation (Emerging)
• Artificial Corneas (Keratoprosthesis)
• Medical Management
o Hypertonic Saline
o Bandage Contact Lenses
o Pain Relief Therapies
By Disease Etiology
• Pseudophakic Bullous Keratopathy
• Fuchs Endothelial Dystrophy
• Post-Surgical Endothelial Damage
• Trauma-Induced Endothelial Loss
• Infection-Related Corneal Damage
• Congenital Endothelial Disorders
By End User
• Hospitals
• Ophthalmic Specialty Clinics
• Eye Banks & Transplant Centers
• Ambulatory Surgical Centers
• Research & Academic Institutes
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72223
Regional Outlook
North America
Leads the global market due to advanced corneal transplant infrastructure, high prevalence of Fuchs dystrophy, and strong adoption of DMEK/DSAEK techniques.
Europe
Shows strong growth supported by established eye banking networks, high surgical volumes, and robust training programs in endothelial keratoplasty.
Asia-Pacific
Fastest-growing region due to large patient pool, expanding cataract surgery programs, rising diabetic population, and improving access to corneal transplantation in India, China, and Southeast Asia.
Latin America & Middle East/Africa
Growing adoption of corneal surgeries driven by better healthcare infrastructure and NGO-led eye care initiatives, though donor tissue availability remains limited in several countries.
Recent Developments
• Advancements in cultured corneal endothelial cell therapy showing positive clinical outcomes.
• Development of ultra-thin and pre-loaded DMEK grafts improving surgical consistency.
• Increasing adoption of artificial cornea implants (keratoprosthesis) for severe cases.
• Expansion of global eye banking capacity through public-private partnerships.
• Research on nanotechnology-based corneal scaffolds for enhanced regeneration.
Expert Quote
"Bullous keratopathy remains a major cause of corneal blindness globally. With breakthroughs in endothelial keratoplasty and regenerative medicine, patient outcomes are improving dramatically, signaling a strong decade of innovation and market growth,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Future Outlook
The Bullous Keratopathy Market is expected to grow steadily as surgical techniques advance and regenerative therapies become more clinically viable. Increasing investments in tissue engineering, artificial corneas, and automation in donor tissue preparation will play a major role in shaping the future of corneal care.
This report is also available in the following languages : Japanese (水疱性角膜症市場), Korean (수포성 각막병증 시장), Chinese (大疱性角膜病市场), French (Marché de la kératopathie bulleuse), German (Markt für bullöse Keratopathie), and Italian (Mercato della cheratopatia bollosa), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72223
Our More Reports:
Microscopic Polyangiitis Market
https://exactitudeconsultancy.com/reports/71749/microscopic-polyangiitis-market
Parainfluenza Virus Infection Market
https://exactitudeconsultancy.com/reports/71751/parainfluenza-virus-infection-market
Staphylococcus aureus Bacteremia Market
https://exactitudeconsultancy.com/reports/71753/staphylococcus-aureus-bacteremia-market
Acute Bacterial Prostatitis Market
https://exactitudeconsultancy.com/reports/71755/acute-bacterial-prostatitis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bullous Keratopathy Market to Grow at a CAGR of 5.4% here
News-ID: 4305343 • Views: …
More Releases from Exactitude Consultancy
Autoimmune Uveitis Patient Pool Expected to Expand at a CAGR of 5.7%
Pune, India - Exactitude Consultancy: The global Autoimmune Uveitis Patient Pool Analysis Market is projected to grow at a CAGR of 5.7% over the forecast period. Growth is driven by increasing diagnosis of autoimmune and inflammatory conditions such as Behçet's disease, sarcoidosis, ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease-each associated with elevated risk of uveitis.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72309
Introduction
Autoimmune uveitis refers to intraocular…
Age-Related Vision Dysfunction Market Set to Grow at a CAGR of 6.5%
Pune, India - Exactitude Consultancy: The global Age-Related Vision Dysfunction Market is projected to grow at a CAGR of 6.5% over the forecast period. Rising life expectancy, expanding aging demographics, and increasing diagnosis of ophthalmic disorders such as cataracts, AMD, glaucoma, and diabetic retinopathy are driving overall market expansion. Technological advancements in diagnostic imaging, surgical equipment, and vision correction therapies continue to strengthen market adoption.
Download Full PDF Sample Copy of…
Age-Related Macular Degeneration (AMD) Market to Grow at a CAGR of 7.1%
Pune, India - Exactitude Consultancy: The global Age-Related Macular Degeneration (AMD) Market is projected to grow at a CAGR of 7.1% over the forecast period. Growth is fueled by rising aging populations, increased case detection through advanced imaging tools, and expanding access to anti-VEGF injections, combination therapies, and emerging gene and cell-based treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72217
Introduction
Age-related macular degeneration (AMD) is the leading cause of irreversible…
Neuromodulation Devices Market to Grow at a CAGR of 10.2%
Pune, India - Exactitude Consultancy: The global Neuromodulation Devices Market is projected to grow at a strong CAGR of 10.2% over the forecast period. Rising prevalence of chronic pain, movement disorders, epilepsy, depression, and other neurological conditions is significantly increasing demand for advanced neuromodulation therapies. Technological advancements-including closed-loop systems, miniaturized implants, wireless charging, and AI-enabled stimulation algorithms-are transforming patient outcomes and driving mass adoption.
Download Full PDF Sample Copy of Market…
More Releases for Bullous
Bullous Keratopathy Market is expected to reach USD 755 million by 2034
Bullous keratopathy is a progressive corneal disorder characterized by corneal endothelial cell dysfunction, leading to corneal edema, blister-like formations, and painful vision loss. It is most commonly associated with aging, cataract surgery complications, and conditions such as Fuchs' endothelial dystrophy. Left untreated, bullous keratopathy can cause severe visual impairment, making it a significant cause of corneal blindness worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72223
As the global burden…
Bullous Pemphigoid Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Bullous pemphigoid (BP) is a rare, chronic, autoimmune blistering skin disorder that primarily affects the elderly population. Characterized by large, fluid-filled blisters, intense itching, and significant discomfort, BP is associated with immune system dysfunction, where antibodies attack proteins in the skin.
Although rare, its prevalence is rising due to aging populations, improved diagnostic accuracy, and increasing autoimmune disease incidence worldwide.
The global bullous pemphigoid market is gaining momentum as awareness grows…
Bullous Pemphigoid Market Projected to Witness Innovation in Autoimmune Therapie …
Bullous Pemphigoid Market Snapshot
The Bullous Pemphigoid Market is projected to grow at a CAGR of 5.8% during the forecast period 2025-2032.
Coherent Market Insights proudly presents its latest Bullous Pemphigoid Market Research Report, delivering a detailed examination of the U.S. Bullous Pemphigoid Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration, and competitive strategies. As the…
Bullous Pemphigoid Treatment Market Size, Share, Analysis Report and Forecast 20 …
According to the report by Expert Market Research (EMR), the global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market. Aided by rising skin disease treatment market and rising accessibility of healthcare facilities, the skin disease treatment market is expected to grow at a CAGR of 3% in the forecast period of 2024-2032.
Bullous pemphigoid is a chronic autoimmune skin disorder characterised by large, tense blisters…
Bullous Keratopathy Treatment Market Size, Share, Industry, Forecast and Outlook …
Bullous Keratopathy Treatment Market Overview
The global Bullous Keratopathy Treatment Market is anticipated to achieve a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030.
Bullous Keratopathy
Bullous keratopathy, also known as corneal edema, is characterized by the swelling of the cornea due to the failure of the corneal endothelium to maintain its transparent and dehydrated state. This condition often results from corneal endothelial dystrophy or trauma. The…
Bullous Pemphigoid Market 2020 Enhancement in Medical Sector
Bullous Pemphigoid - Pipeline Insight, 2020
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Bullous Pemphigoid Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This…
